Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISEREDE FYSIOTERAPEUTER ÅBOULEVARDEN 70 ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   1.4% 1.4% 1.3% 1.4% 1.5% 1.4% 10.2% 4.6%   Credit score (0-100)   80 79 80 78 74 77 23 46   Credit rating   A A A A A A BB BBB   Credit limit (kDKK)   35.2 14.1 25.7 32.7 10.0 19.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,091 2,659 2,150 2,771 2,782 3,693 0.0 0.0   EBITDA   1,368 1,725 1,379 2,106 1,782 2,086 0.0 0.0   EBIT   921 1,279 940 1,661 1,332 1,626 0.0 0.0   Pre-tax profit (PTP)   909.9 1,229.8 891.3 1,623.7 1,313.0 1,623.3 0.0 0.0   Net earnings   707.3 956.1 693.7 1,263.7 1,030.1 1,265.9 0.0 0.0   Pre-tax profit without non-rec. items   910 1,230 891 1,624 1,313 1,623 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   396 333 327 266 406 329 0.0 0.0   Shareholders equity total   2,850 1,356 1,450 2,114 1,944 2,010 0.0 0.0   Interest-bearing liabilities   625 1,156 1,006 0.0 0.1 0.0 1,818 1,818   Balance sheet total (assets)   5,221 4,050 3,872 3,557 3,091 3,336 1,818 1,818   Net Debt   21.2 1,125 958 -334 -90.9 -361 1,818 1,818     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,091 2,659 2,150 2,771 2,782 3,693 0.0 0.0   Gross profit growth   -20.2% 27.2% -19.1% 28.9% 0.4% 32.7% -100.0% 0.0%   Employees   2 3 2 2 3 4 0 0   Employee growth %   0.0% 50.0% -33.3% 0.0% 50.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,221 4,050 3,872 3,557 3,091 3,336 1,818 1,818   Balance sheet change%   -11.8% -22.4% -4.4% -8.1% -13.1% 7.9% -45.5% 0.0%   Added value   921.4 1,278.8 939.5 1,661.2 1,332.0 1,626.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -779 -893 -828 -889 -693 -920 -329 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   44.1% 48.1% 43.7% 60.0% 47.9% 44.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.5% 27.6% 23.7% 44.7% 40.1% 50.6% 0.0% 0.0%   ROI %   19.8% 33.5% 28.9% 55.2% 49.9% 65.2% 0.0% 0.0%   ROE %   20.6% 45.5% 49.4% 70.9% 50.8% 64.0% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   54.6% 33.5% 37.4% 59.4% 62.9% 60.2% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1.6% 65.2% 69.5% -15.8% -5.1% -17.3% 0.0% 0.0%   Gearing %   21.9% 85.2% 69.4% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 5.5% 4.5% 7.5% 31,648.3% 4,663.3% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   0.7 0.2 0.3 0.8 0.7 1.2 0.0 0.0   Current Ratio   0.7 0.2 0.3 0.9 0.8 1.3 0.0 0.0   Cash and cash equivalent   603.8 30.6 47.9 333.6 91.0 360.6 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -449.3 -1,581.3 -1,121.0 -87.0 -107.2 255.2 -909.1 -909.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   461 426 470 831 444 407 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   684 575 690 1,053 594 521 0 0   EBIT / employee   461 426 470 831 444 407 0 0   Net earnings / employee   354 319 347 632 343 316 0 0